3[1] Tett SE,Cutler DJ,Day RO.Bioavailability of hydroxychloroquinetablets assessed with deconvolution techniques[J].J Pharm Sic，1992;81:155
4[2] McChesney EW. Animal toxicity and pharmacokinetics of hydroxychlo-roquine sulfate[J].Am J Med，1983;75(suppl 1):11
5[3] Hurst NP, French JK, Bell AL,et al.Differential effects of mepacrine,chloroquine and hydroxychloroquine on superoxide anion generation,phospholipid methylation and arachidonic acid release by human blood monocytes[J].Biochem Pharmacol，1986;35:3083
6[4] Wallace DJ,Linker-Israeli M,Metzger AL,et al.The relevance ofantimalarial therapy with regard to thrombosis,hypercholesterolemia,and cytokines in SLE.Lupus[J] 1993;2(suppl 1):S13
7[5] Munro R,Morrison E,McDonald AG,et al.Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis[J].Ann Rheum Dis,1997;56(6):374
